U.S. flag

An official website of the United States government

NM_000071.3(CBS):c.262C>G (p.Pro88Ala) AND HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 13, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002601595.3

Allele description [Variation Report for NM_000071.3(CBS):c.262C>G (p.Pro88Ala)]

NM_000071.3(CBS):c.262C>G (p.Pro88Ala)

Gene:
CBS:cystathionine beta-synthase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.3
Genomic location:
Preferred name:
NM_000071.3(CBS):c.262C>G (p.Pro88Ala)
HGVS:
  • NC_000021.9:g.43068563G>C
  • NG_008938.1:g.12368C>G
  • NM_000071.3:c.262C>GMANE SELECT
  • NM_001178008.2:c.262C>G
  • NM_001178008.3:c.262C>G
  • NM_001178009.3:c.262C>G
  • NM_001320298.2:c.262C>G
  • NP_000062.1:p.Pro88Ala
  • NP_000062.1:p.Pro88Ala
  • NP_001171479.1:p.Pro88Ala
  • NP_001171480.1:p.Pro88Ala
  • NP_001307227.1:p.Pro88Ala
  • LRG_777t1:c.262C>G
  • LRG_777:g.12368C>G
  • LRG_777p1:p.Pro88Ala
  • NC_000021.8:g.44488673G>C
  • NM_000071.2:c.262C>G
Protein change:
P88A
Molecular consequence:
  • NM_000071.3:c.262C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178008.3:c.262C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178009.3:c.262C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320298.2:c.262C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED
Identifiers:
MedGen: C3150344

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002949845Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Sep 13, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations.

Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G.

Am J Hum Genet. 1995 Jun;56(6):1324-33.

PubMed [citation]
PMID:
7762555
PMCID:
PMC1801112

Surrogate genetics and metabolic profiling for characterization of human disease alleles.

Mayfield JA, Davies MW, Dimster-Denk D, Pleskac N, McCarthy S, Boydston EA, Fink L, Lin XX, Narain AS, Meighan M, Rine J.

Genetics. 2012 Apr;190(4):1309-23. doi: 10.1534/genetics.111.137471. Epub 2012 Jan 20. Erratum in: Genetics. 2012 Oct;192(2):759-60.

PubMed [citation]
PMID:
22267502
PMCID:
PMC3316645
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002949845.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 88 of the CBS protein (p.Pro88Ala). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Pro88 amino acid residue in CBS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7762555, 22267502). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CBS protein function. This variant has not been reported in the literature in individuals affected with CBS-related conditions. This variant is not present in population databases (gnomAD no frequency).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024